Description of Measure | Burden of comorbidities and complications of CKD, by CKD.
|
---|
Data Set | National Health and Nutrition Examination Survey (NHANES). |
---|
Population | Noninstitutionalized US adults aged ≥ 18 years, pregnant women excluded. |
---|
Years Included | 2005–March 2020. |
---|
Numerator | U.S. adults aged ≥ 18 years with hypertension, diabetes, or anemia and U.S. adults aged ≥ 20 years with cardiovascular disease. |
---|
Denominator | U.S. adults aged ≥ 18 years with serum creatinine, urine albumin and creatinine, blood pressure, and hemoglobin values; self-reported diabetes and cardiovascular disease status and treatments. |
---|
Definition of CKD | CKD is defined by an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m² or albuminuria (urine albumin to creatinine ratio [UACR] ≥30 mg/g). Estimates are based on single estimates of eGFR and UACR. |
---|
Estimated Glomerular Filtration Rate (eGFR) | Based on the CKD-EPI (2021) equation for calibrated creatinine: eGFR=142 x [min(serum creatinine in mg/dL) /κ, 1)]**α x [max(serum creatinine/κ, 1)]**-1.20 x 0.9938**age x (1.012 if female).
κ = 0.7 if female and 0.9 if male
α = -0.241 if female and -0.302 if male
** = raise to the power
|
---|
Albuminuria | UACR is calculated as urine albumin divided by urine creatinine. Albuminuria is defined as UACR ≥ 30 mg/g. |
---|
Serum Creatinine | Serum creatinine values used for eGFR calculation are standardized against isotope dilution mass spectrometry (IDMS). |
---|
Urine Albumin | Measured in random urine collection by fluorescent immunoassay. |
---|
Diabetes | Diabetes is defined by self-report of diabetes, treatment with insulin or oral anti-diabetes medications, or HbA1c ≥ 6.5%. |
---|
Hypertension | Hypertension is defined by self-reported hypertension, treatment with hypertension medications, or average systolic blood pressure greater than 140 mmHg (130 mmHg for CKD and diabetes) and diastolic blood pressure greater than 90 mmHg (80 mmHg for CKD and diabetes). |
---|
Cardiovacular Disease (CVD) | Cardiovascular disease is defined by a self-reported affirmative response to one or more of the questions: “Ever told had congestive heart failure?”, “Ever told had coronary heart disease?”, “Ever told you had angina/angina pectoris?”, “Ever told you had heart attack?”, or “Ever told you had stroke?”. |
---|
Anemia | Anemia is defined by hemoglobin < 13 g/dl for males and < 12 g/dl for females. |
---|
Age Standardization | Estimates were standardized to the 2010 U.S. Census population for adults: 18–39 years: 37.1%, 40–59 years: 38.1%, 60–69 years: 12.8%, and 70+ years: 12.0%. |
---|
Limitations of Indicator | Albuminuria and kidney function are assessed from one-time cross-sectional measurements, possibly overestimating CKD prevalence. |
---|
Analytical Considerations | Appropriate NHANES survey weights are used for all analyses; if the relative standard error is greater than 30%, the estimates are not shown. Serum creatinine measurements are assay corrected for NHANES years 2005 and 2006 to be combined with later years. |
---|